Application of trilobatin in preparing medicine for treating alzheimer disease
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for Alzheimer's disease and trilobatin, which is applied in the field of pharmacy to achieve the effect of easy access, wide source and good therapeutic effect
Inactive Publication Date: 2018-08-17
ZUNYI MEDICAL UNIVERSITY
View PDF1 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
But so far there is no report of anti-AD
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0028] A kind of application of trilobatin in the preparation of medicine for treating Alzheimer's disease, take trilobatin 5g, medicinal starch 75g, microcrystalline cellulose 20g, medicinal starch is first dried, crosses 120 mesh sieves, and three Leaf glycosides and microcrystalline cellulose are mixed, passed through a 120-mesh sieve twice, and filled into hard capsules to make 1000 capsules of the present invention; each hard capsule contains 0.5 mg of the main ingredient.
Embodiment 2
[0030] A kind of application of trilobatin in the preparation of medicine for treating Alzheimer's disease, get trilobatin 5g, hypromellose 6g, sodium starch glycolate 10g, microcrystalline cellulose 8g, lactose 115g, starch 50g, hard Magnesium stearate 1g; fully mix trelobatin with hypromellose, sodium starch glycolate, microcrystalline cellulose, lactose, starch, magnesium stearate and put it into a high-speed blender, spray with appropriate amount of water, Controlled at 3-4%, then compressed into tablets, made into 1000 tablets, coated with film.
Embodiment 3
[0032] An application of trilobatin in the preparation of medicines for treating Alzheimer's disease. Take 5g of trilobatin, add 400ml polyethylene glycol 200 to dissolve, then add appropriate amount of distilled water to dilute, then add appropriate amount of sucrose and adjust the volume to 1000ml , stir well, filter, fill into 10ml or 20ml each, and sterilize the package.
[0033] The invention adopts the Alzheimer's disease rat model induced by Aβ25-35 to study the therapeutic effect of trilobatin on the Alzheimer's disease. After the rat model of Alzheimer's disease was established by bilateral hippocampal injection of Aβ25-35, trilobatin (10 mg / kg) was given for 15 days. It was found that trelobatin has therapeutic effect on Alzheimer's disease, and can significantly reduce the release of pro-inflammatory factors (TNF-α and IL-1β) and the expression of TLR4, MyD88, and NF-κB.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to application of trilobatin in preparing a medicine for treating an alzheimer disease. The medicine is prepared through the steps of adopting 5g of trilobatin, 75g of medicinalstarch and 20g of microcrystalline cellulose; firstly drying the medicinal starch, screening through a 120-mesh sieve, then mixing the trilobatin and the microcrystalline cellulose, screening throughthe 120-mesh sieve for two times, filling in a hard capsule, and obtaining 1000 pcs of capsules, wherein each hard capsule contains 0.5mg of main medicine component. According to the application of the trilobatin in preparing the medicine for treating the alzheimer disease provided by the invention, the trilobatin is adopted to prepare the re-perfused medicine for treating the alzheimer disease, and through animal experimental verification, the prepared medicine composition can be used for treating the alzheimer disease. The materials are wide in source, easy to get, simple and practical to prepare the medicine, and good in treatment effect.
Description
technical field [0001] The invention relates to the application of trelobatin in the preparation of medicines for treating Alzheimer's disease, belonging to the technical field of pharmacy. Background technique [0002] Alzheimer's disease (Alzheimer disease, AD) is one of the most common types of dementia, accounting for more than 60% of the incidence of dementia. The typical pathological features of AD are the formation of senile plaques (SP) caused by the deposition of extracellular β-amyloid (Aβ) and the formation of neurofibrillary tangles caused by hyperphosphorylation of tau protein , NFTs) and neuron loss accompanied by obvious synaptic loss, etc. These pathological changes lead to memory loss, mental disorders and movement disorders in patients, which seriously affect the daily life of patients and bring heavy burdens to families and society. [0003] Alzheimer's disease is a heterogeneous disease with multiple causes. Its etiology and pathogenesis have not been fu...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more